Bio-Techne
TECH
576 hedge funds and large institutions have $11.3B invested in Bio-Techne in 2024 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 220 increasing their positions, 195 reducing their positions, and 50 closing their positions.
921% more call options, than puts
Call options by funds: $12.9M | Put options by funds: $1.27M
50% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 50
13% more repeat investments, than reductions
Existing positions increased: 220 | Existing positions reduced: 195
3% more funds holding
Funds holding: 561 → 576 (+15)
1.17% more ownership
Funds ownership: 97.5% → 98.67% (+1.2%)
9% less capital invested
Capital invested by funds: $12.4B → $11.3B (-$1.06B)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$90.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$40.7M |
| 3 |
Select Equity Group
New York
|
+$36.4M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$33.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$26.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$89.7M |
| 2 |
Millennium Management
New York
|
-$45.2M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$34.2M |
| 4 |
EP
Eversept Partners
New York
|
-$26.7M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$22.8M |
TECH Hedge Fund Activity: Q4 2024 in Review
576 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2024, worth a combined $11.3B — down 8.6% from $12.4B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new TECH positions and 50 closed out — a net gain of 25 holders — while 220 added to existing stakes and 195 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $90.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $89.7M sold.
- 576 institutional investors held Bio-Techne (TECH) as of Q4 2024, up from 561 in Q3 2024.
- Funds reported $11.3B of Bio-Techne stock for Q4 2024, down 8.6% quarter-over-quarter.
- 75 funds opened new Bio-Techne positions in Q4 2024 and 50 closed out, a net change of +25 holders.
- The largest Bio-Techne buyer in Q4 2024 was T. Rowe Price Associates, an estimated $90.3M added.
- The largest Bio-Techne seller in Q4 2024 was Point72 Asset Management, an estimated $89.7M sold.
Based on aggregated 13F filings for Q4 2024.